Maravai LifeSciences Holdings Non-GAAP EPS of -$0.08 in-line, revenue of $41.6M misses by $7.42M

* Maravai LifeSciences Holdings press release [https://seekingalpha.com/pr/20297746-maravai-lifesciences-reports-third-quarter-2025-financial-results] (MRVI [https://seekingalpha.com/symbol/MRVI]): Q3 Non-GAAP EPS of -$0.08 in-line.
* Revenue of $41.6M (-36.2% Y/Y) misses by $7.42M.
* Revenue for the full year 2025 is expected to be approximately $185.0 million.

MORE ON MARAVAI LIFESCIENCES HOLDINGS

* Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4812438-maravai-lifesciences-holdings-inc-mrvi-q2-2025-earnings-call-transcript]
* Maravai LifeSciences Holdings, Inc. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4812437-maravai-lifesciences-holdings-inc-2025-q2-results-earnings-call-presentation]
* Maravai LifeSciences Holdings Q3 2025 Earnings Preview [https://seekingalpha.com/news/4516055-maravai-lifesciences-holdings-q3-2025-earnings-preview]
* Goldman's 48 potential M&A candidates [https://seekingalpha.com/news/4499689-goldmans-48-potential-ma-candidates]
* Seeking Alpha’s Quant Rating on Maravai LifeSciences Holdings [https://seekingalpha.com/symbol/MRVI/ratings/quant-ratings]